A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment

A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment

Abstract Background Brain metastasis (BM) comprises the most common reason for crizotinib failure in patients with anaplastic lymphoma kinase (ALK)‐rearranged non–small cell lung cancer (NSCLC). We hypothesize that its occurrence could be predicted by a computed tomography (CT)‐based radiomics model...

Full description

Bibliographic Details
Main Authors: Yongluo Jiang, Yixing Wang, Sha Fu, Tao Chen, Yixin Zhou, Xuanye Zhang, Chen Chen, Li‐na He, Wei Du, Haifeng Li, Zuan Lin, Yuanyuan Zhao, Yunpeng Yang, Hongyun Zhao, Wenfeng Fang, Yan Huang, Shaodong Hong, Li Zhang
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Thoracic Cancer
Subjects:
ALK‐positive
image biomarkers
lung cancer
response prediction
targeted therapy
Online Access:https://doi.org/10.1111/1759-7714.14386

Internet

https://doi.org/10.1111/1759-7714.14386

Similar Items